Search research articles
Contact Us
Filters
Showing results (31-40 of 251) with videos related to
Page
of 26
Sort By:
Nature Reviews. Drug Discovery
|
August 2, 2011
Abiraterone acetate
Christopher J Logothetis, Eleni Efstathiou, Fil Manuguid, et al.
Journal of Cell Science & Therapy
|
August 9, 2021
Application of a Successful Germ Cell Tumor Paradigm to the Challenges of Common Adult Solid Cancers
Shi-Ming Tu, Matthew Campbell, Amishi Shah, et al.
Biomaterials
|
January 26, 2019
Engineered bone for probing organotypic growth and therapy response of prostate cancer tumoroids in vitro
Claudia Paindelli, Nora Navone, Christopher J Logothetis, et al.
Journal of the National Cancer Institute
|
September 16, 2011
Novel therapies for metastatic castrate-resistant prostate cancer
Farshid Dayyani, Gary E Gallick, Christopher J Logothetis, et al.
Clinical Advances in Hematology & Oncology : H&O
|
June 17, 2010
Multimodality therapy: bone-targeted radioisotope therapy of prostate cancer
Shi-Ming Tu, Sue-Hwa Lin, Donald A Podoloff, et al.
Frontiers in Oncology
|
September 5, 2025
Biomarkers to optimize PSMA-targeted radioligand therapy for metastatic castration-resistant prostate cancer
Himisha Beltran, Jeremie Calais, Louise Emmett, et al.
Computational and Mathematical Methods in Medicine
|
December 25, 2013
Modified logistic regression models using gene coexpression and clinical features to predict prostate cancer progression
Hongya Zhao, Christopher J Logothetis, Ivan P Gorlov, et al.
European Urology
|
July 14, 2019
Prostate Cancer: Quo Vadis?
Christopher J Logothetis, Ana Aparicio, Filippos Koinis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 10, 2005
Pathogenesis and treatment of prostate cancer bone metastases: targeting the lethal phenotype
Robert D Loberg, Christopher J Logothetis, Evan T Keller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2015
Management of Clinical Stage I Testicular Cancer: How Should We Define Success?
Lance C Pagliaro, Nizar M Tannir, Shi-Ming Tu, et al.
Page
of 26
Search research articles
Search
Showing results (31-40 of 251) with videos related to
Sort By:
Page
of 26
Nature Reviews. Drug Discovery
|
August 2, 2011
Abiraterone acetate
Christopher J Logothetis, Eleni Efstathiou, Fil Manuguid, et al.
Journal of Cell Science & Therapy
|
August 9, 2021
Application of a Successful Germ Cell Tumor Paradigm to the Challenges of Common Adult Solid Cancers
Shi-Ming Tu, Matthew Campbell, Amishi Shah, et al.
Biomaterials
|
January 26, 2019
Engineered bone for probing organotypic growth and therapy response of prostate cancer tumoroids in vitro
Claudia Paindelli, Nora Navone, Christopher J Logothetis, et al.
Journal of the National Cancer Institute
|
September 16, 2011
Novel therapies for metastatic castrate-resistant prostate cancer
Farshid Dayyani, Gary E Gallick, Christopher J Logothetis, et al.
Clinical Advances in Hematology & Oncology : H&O
|
June 17, 2010
Multimodality therapy: bone-targeted radioisotope therapy of prostate cancer
Shi-Ming Tu, Sue-Hwa Lin, Donald A Podoloff, et al.
Frontiers in Oncology
|
September 5, 2025
Biomarkers to optimize PSMA-targeted radioligand therapy for metastatic castration-resistant prostate cancer
Himisha Beltran, Jeremie Calais, Louise Emmett, et al.
Computational and Mathematical Methods in Medicine
|
December 25, 2013
Modified logistic regression models using gene coexpression and clinical features to predict prostate cancer progression
Hongya Zhao, Christopher J Logothetis, Ivan P Gorlov, et al.
European Urology
|
July 14, 2019
Prostate Cancer: Quo Vadis?
Christopher J Logothetis, Ana Aparicio, Filippos Koinis, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
November 10, 2005
Pathogenesis and treatment of prostate cancer bone metastases: targeting the lethal phenotype
Robert D Loberg, Christopher J Logothetis, Evan T Keller, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 3, 2015
Management of Clinical Stage I Testicular Cancer: How Should We Define Success?
Lance C Pagliaro, Nizar M Tannir, Shi-Ming Tu, et al.
Page
of 26